Summary. Glucose deprivation of L6 myocytes results in the upregulation of glucose transporter activity, protein and mRNA. We have investigated the downregulation of transporter gene expression by glucose and other hexoses in glucose-deprived L6 myocytes. Glucose transport activity was measured as the uptake of 3H-2-deoxyglucose. Transporter protein and mRNA were detected by immunoblot and Northern blot analysis, respectively, with probes to the rat brain glucose transporter. Glucose deprivation of myocytes, in the absence and presence of insulin, increased 3H-2-deoxygluc0se uptake, transporter protein and mRNA levels. Refeeding with glucose reversed the glucose deprivation effects on transport activity and mRNA within 12 h, with half-maximal effects at 1-2 mmol/1 glucose. Mannose fully substituted for glucose. Refeeding with the non-metabolisable glucose analogues 2-deoxyglucose and 3-0-methylglucose, or with glucosamine or mannitol, downregulated 3H-2-deoxyglucose uptake but had little or no effect on transporter protein and mRNA expression. In contrast, glucose-6-phosphate markedly increased 3H-2-deoxyglucose uptake but partly downregulated transporter mRNA levels, whereas galactose had a small stimulatory effect on both 3H-2-deoxyglucose uptake and transporter mRNA; neither affected transporter protein levels. The transporter mRNA level was not affected by several metabolites (pyruvate, glyceraldehyde, glycerol) and amino acids (alanine, glutamine). These findingsindicate that (i) there are independent pathways for hexose regulation of transport activity, protein and mRNA and (ii) down-regulation of transporter mRNA requires metabolism beyond hexose phosphate whereas glucose uptake may be regulated by direct interaction of hexoses with the transporter.
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The facilitated glucose transporter is an integral membrane glycoprotein which mediates the energy-independent transport of glucose across the plasma membrane. The glucose transporter was first cloned from human HepG2 cells [1] and rat brain [2] . While the HepG2/brain-type transporter has been a prototype for studies of transporter gene expression it is now known to belong to a family of related proteins which display tissue specific expression and may be functionally distinct [3] [4] [5] [6] [7] [8] . The HepG2/brain-type transporter is regulated at the level of gene and mRNA expression in different physiological states [9, 10] by hormones and growth factors [11] [12] [13] [14] [15] and by hexose availability [16, 17] .
Glucose deprivation increases glucose transport activity (Vm~) in a range of cells including myocytes [18] [19] [20] [21] [22] [23] [24] [25] [29] [30] [31] , whereas hyperglycaemia or glucose refeeding decreases glucose transport activity [20, [26] [27] [28] . The glucose deprivation-induced increase in glucose transport is associated with an increase in the number of transporters at the plasma membrane [32] or in the total transporter pool, due either to a decrease in transporter degradation [33] or an increase in transporter biosynthesis [30] . However, hexose regulation of the transporter may occur at the level of protein turnover, independently of changes in translation or transcription, eg. in glucose deprived 3T3-C2 fibroblasts the total amount of transporter protein increased without alteration of the translational efficiency or the amount of transporter mRNA [33] . In cultured glial cells and L6 myocytes glucose deprivation resulted in an increase in the amount of the HepG2/brain-type glucose transporter mRNA which could be reversed by refeeding cells with glucose [16, 17] . Although other studies have demonstrated that the regulation of glucose transport activity and protein level requires both direct interaction of glucose or other hexose with the transporter and the generation of hexose phosphate [25, 29, 33] , these requirements are not known with respect to the regulation of mRNA expression.
We have used L6 myocytes to investigate the glucosedependent down-regulation of the glucose transport sys- mRNA by giucose deprivation and insulin. L6 myocytes were grown and differentiated in medium containing 5 mmol/1 glucose. At time = 0 h the medium was changed to either DME containing 5 mmol/1 glucose without (-O -) and with ( 9 1 gmol/1 insulin or glucose-free DME without ( [] ) or with ( 9 ) i gmol/1 insulin, a 3H-2DG uptake expressed as pmol. mg protein 1.10 min -1. Each value is the mean _+ SD of 3-6 determinations, b Northern blot analysis of total RNA (25 gg/lane) with an oligonucleotide to the rat brain glucose transporter. Glucose transporter mRNA, 2.8 kb, Intensity of the bands was quantified by laser densitometry and plotted as arbitrary densitometer units, c Immtmoblot of membrane protein (20 gg/lane) with antiserum to the C-terminal peptide of the rat brain glucose transporter. Lane 1, glucose fed, Lane 2, glucose deprived, 24 h. Molecular weight markers are 97, 68, 43, 29 and 18 kDa. The bands at 55, 50 and 43 kDa in this preparation are non-specific tern following glucose deprivation and the hexose specificity a n d m e t a b o l i c r e q u i r e m e n t s for regulation of glucose transport activity, p r o t e i n and m R N A .
Materials and methods

Cell culture
Rat L6 myocytes, a subclone of the original L6 line isolated by Yaffe [34] , were provided by Dr E J. Ballard, (CSIRO Division of Human Nutrition, Adelaide, Australia). Myocytes were grown to confluence in Minimal Essential Medium (MEM) (5 mmol/1 glucose) containing 10% fetal calf serum (FCS). Differentiation into multinucleated myotubes was obtained by reducing the FCS to 2%. The medium was changed every 2-3 days until spontaneous contraction of myotubes was observed (usually 8-10 days). Glucose deprivation studies were done with serum-free, glucose-free Dulbecco's modified Eagle medium (DME), with control fed cells in DME containing 5 retool/1 glucose. Myocytes were viable for up to 48 h in glucosefree medium. For refeeding, sugars and metabolites were added directly to the medium from 1 tool/1 stock solutions. Porcine insulin was purchased from CSL-Novo (Melbourne, Australia). Sugars and metabolites were from Sigma (St. Louis. Mo, USA).
3H-2-deoxy-D-glucose (3H-2DG) uptake
To determine the rate of 3H-2DG uptake cells were washed in glucose free Krebs Ringer bicarbonate buffer with Hanks salts (HKRB) and incubated in i ml HKRB with 3 gCi 2-deoxy-D-[1-3H]-glucose (Amersham International, Amersham, UK., 17 Ci/mmol) for 10 min at 37~ washed with ice cold phosphate buffered saline (PBS), solubilised in I ml of 1 N NaOH and counted in a liquid scintillation spectrometer. Non-spedfic uptake, measured in the presence of cytochalasinB (50gmol/1) or phloretin (500gmol/1), was <7% of total uptake and was subtracted from total uptake. 3H-2D G uptake is expressed as pmol. mg cell protein -1.10 rain -1.
RNA extraction, Northern and slot blotting
Total cytoplasmic RNA was extracted as previously described [15, 35] . Cells were resuspended in ice cold lysis buffer (0.5% NP40, 10 mmol/l Tris. HC1 pH 7.5,150 retool/1 NaC1, 2 mmol/l MgC12) and the nuclei pelleted at 2000 g for 5 rain at 4~ The lysate was combined with an equal volume of sodium dodecyl sulphate (SDS)/urea solution (1% SD S, 7 tool/1 urea, 350 retool/1NaC1, 10 mmol/l EDTA, 100 lnmol/1 Tris. HC1 pH 7.5) and extracted with phenol:chloroform :isoamylalcohol (50:50:1). RNA was quantified by spectrophotometry at 260 nm. For Northern blots, RNA was electrophoresed in 1% agarose/2.2mol/1 formaldehyde gels in MOPS buffer (20 retool/13-[N-morpholino]propane sulfonic acid, 1 retool/1 EDTA, 5 mmol/1 sodium acetate pH 7.0), stained with ethidium bromide and transferred to nitrocellulose with 20 x SSC (3 tool/1 sodium chloride, 1.3 mol/l sodium citrate). For slot blots, RNA was heat denatured (65~ 15rain) in 2.2mol/1 formaldehyde, 5xSSC, MOPS buffer. Samples were filtered through nitrocellulose and washed with 15 x SSC. Filters were baked in vacuo for 2 h, prehybridised for 4-6 h in 50% formamide, 5 x SSC, 5 Denhardt's solution, 500 gg/ml sheared salmon testis DNA and 1% SDS at 42 ~ and hybridised for 18 h at 42 ~ in buffer containing 32p-labelled probes. Filters were washed for 2 h in 2 x SSC/0.1% SDS at room temperature and 0,2 x SSC/0.1% SDS at 42 ~ for 30 min, then autoradiographed on Amersham Hyperfilm Multi Purpose (MP). mRNA levels were quantified by scanning the autoradiographs in an LKB Ultroscan laser densitometer (Turku, Finland) and computer fitted integration. Each lane was scanned 2-3 times.
Glucose transporter mRNA (GTmRNA) was detected with an oligonucleotide probe (RGT-1) to the rat brain glucose transporter sequence [2] . RGT-1 is complementary to nucleotides 904-942 with-in the cytoplasmic loop region of the transporter. Under the stringency conditions used RGT-1 barely detects GTmRNA in HepG2 cells; the corresponding region of HepG2 transporter sequence (nucleotides 697-735; [1] differs by 5 nucleotides. It is highly unlikely that this probe would recognize the adipose/muscle glucose transporter which differs by 16 nucleotides in the corresponding region [7] , but it may recognize other glucose transporter subtypes which are identical in this region of the RNA sequence. An oligo(dT) 30 mer (TT30) was used for quantification of poly(A) + RNA loading on the slot blot shown in Figure 2 . Oligonucleotides were 5'-end labelled with,/-32p-ATP and T4 polynucleotide kinase (specific activity 108 cpm/gg). A cDNA probe to beta-tubulin was labelled with c~-32p-dATP by random priming (specific activity 109 cpm/gg).
Membrane preparation and immunoblotting
Cell membranes were isolated as previously described [36] by incubating cells in hypotonic buffer (10 mmol/l Hepes pH 7.5, 0.5 mmol/1 MgC12) for 30 min at 4~ grinding in a Dounce homogeniser and removal of nuclei by centrifugation at 2500 rev/min for 5 rain at 4~ Membranes were pelleted at 13 000 rev/min for 10 min at 4 ~ and resuspended in 0.1 mol/l Tris. HC1 pH 6.8, 0.1 tool/1 dithiothreitol, 0.1% SDS, 10% glycerol, 0.1% bromophenol blue. Membrane protein (25 gg) was heated at 65 ~ for 5 min and size fractionated, along with BioRad prestained high molecular weight markers, in 10% SDS-polyacrylamide gels in the Hoefer Mighty Small electrophoresis system and transferred to nitrocellulose in an LKB Novablot electrophoretic transfer kit. Filters were blocked for 2 h with phosphate buffered saline (PBS) containing 0.05% Tween20 (PBS/Tween) and 5% milk powder then incubated for 12 h at 4 ~ with PBS/Tween/l% BSA containing antiserum. Filters were then washed, incubated in 5 ml PBS/Tween/1% BSA containing 1 gCi ~25I-protein A for I h at room temperature, washed in PBS/0.2% Tween and autoradiographed. Glucose transporter protein was detected with a 1/200 dilution of a rabbit antiserum raised against the C-terminal peptide (amino acids 480M92) of the rat brain glucose transporter [37] . It is unlikely that this antiserum would detect the adipose/muscle-type glucose transporter which has no homology in the C-terminal amino acid sequence [7] but it may recognise other glucose transporter subtypes with similar C-terminal sequence. For antibody blocking experiments undiluted antiserum was incubated for 1 h at room temperature with 0.1 rag/rot C-terminal peptide. Transporter protein was quantified by scanning densitometry of the autoradiographs.
Results
Stimulation of glucose transporter activity, protein and mRNA expression by glucose deprivation and insulin
In order to investigate hexose-dependent regulation of glucose transporter gene expression we first confirmed that glucose deprivation caused induction of the glucose transporter system in this subclone of L6 myocytes. The results are similar to those reported by Walker et al. [17] . Chronic glucose deprivation caused time-dependent stimulation of the rate of 3H-2DG uptake (four-fold) (Fig. 1 a) and increased levels of HepG2/brain-type glucose transporter m R N A (two-to four-fold) (Fig. i b) and protein (ten-fold) (Fig. lc) . In control glucose-fed cells antiserum to the C-terminal peptide of the rat brain transporter detected a low abundance protein which migrated as a diffuse band with apparent molecular weight of 45-50 kilodalton (kDA) (Fig. lc) . In glucose-deprived cells there was no consistent change in the amount of 45-50 k D A transporter but a sharp protein band with appar- Fig.4 . Dose response effect of glucose refeeding on 3H-2DG uptake and GTmRNA expression. Myocytes were incubated in glucosefree medium containing 1 ~mol/l insulin for 12 h to stimulate transporter expression. Glucose was added at concentrations up to 10 mmol/1, incubation proceeded for 12 h and 3H-2DG uptake and GTmRNA levels were measured. 3H-2D G uptake values (,~ .,~), expressed as cpm/mg protein, are the mean _+ SD of triplicate determinations. GTmRNA values ( 9169 are the mean + SD (arbitrary densitometer units) of three Northern blots probed with an oligonucleotide to the rat brain glucose transporter, quantified by laser densitometry
Effect of glucose concentration on insulin-stimulated glucose transporter expression
Previously we found that insulin and IGF-1 stimulated glucose transporter mRNA expression in L6 myocytes at the standard medium glucose concentration of 5 mmol/1 [15] . The experiments shown in Figure 2 directly compare the effects of i gmol/1 insulin, at different glucose concentrations, on GTmRNA expression. Insulin stimulated GTmRNA levels approximately five times both in the absence of glucose and in the presence of 5 mmol/1 or 25 mmol/1 glucose. This increase in GTmRNA was evident when compared to the amount of poly(A) § loaded (Fig. 2 b) and was independent of changes in betatubulin expression which was decreased in glucose deprived cells and increased (-two-fold) by insulin in fed cells but not in glucose deprived cells (Fig. 2 a) . Thus, glucose deprivation prevented the stimulatory effect of insulin on beta-tubulin mRNA but not on GTmRNA. These data suggest that the glucose concentration does not alter the ability of insulin to stimulate GTmRNA expression.
Reversal of the glucose deprivation effects on glucose transporter activity and mRNA by glucose: time course and dose response
Following induction of L6 myocyte gIucose transporter expression by glucose deprivation a second incubation was performed in the same medium with or without glucose. Qualitatively the same results were obtained with or without insulin in the medium. The increase in both 3H-2DG uptake and GTmRNA levels was reversed by glucose in a time-and concentration-dependent manner. The rate of 3H-2DG uptake and the amount of GTmRNA decreased in parallel, with a 50% decrease in 6-8 h reaching basal levels in 12-14 h (Fig.3) . The concentration-dependence for glucose reversal of 3H-2DG uptake and GTmRNA was the same, the half-maximal decrease occurring with 1-2 mmol/1 glucose and maximal decrease at 5 mmol/1 glucose (Fig. 4) .
Hexose specificity for downreguIation of glucose transporter expression
A range of glucose analogues, sugars and metabolites was examined for the ability to replace glucose in the downregulation of glucose transporter expression. The ability of hexoses to compete with 3H-2DG uptake in L6 myocytes has been described [18, 38] .
Myocytes were incubated in glucose-free medium containing insulin followed by chronic exposure to hexose. 3H-2DG uptake was downregulated to a similar extent (40-60%) by glucose, 2-deoxyNucose, mannose, 3-O-methylglucose and mannitol (Table 1) . Galactose caused a small increase in 3H-2DG uptake, whereas glucosamine markedly reduced the rate of glucose uptake (by 80%). Glucose-6-phosphate upregulated (by 66%) the rate of 3H-2DG uptake. Sucrose had no significant effect.
Refeeding with glucose and mannose reversed the induction of the 40 kDa transporter species and caused a small increase in the amount of the 45-50 kDa transporter species (Fig. 5) , but the total amount of transporter in refed cells (40 kDa + 45-50 kDa species) was less than the total amount of 40 kDa transporter in glucose-deprived cells. Galactose alone had no effect on transporter were incubated in glucose-free medium containing 1 gmol/1 insulin for 12 h to stimulate transporter expression. Hexose (20 mmol/t) was added to the medium and incubation continued for 12 h. Membranes (25 gg) were analysed by immunoblotting with antiserum to the rat brain glucose transporter C-terminal peptide. CONT, no hexose; GLC, glucose; MAN, mannose; GAL, galactose; 2DG, 2-deoxyglucose; 3MG, 3-O-methylglucose; G6P, glucose-6-phosphate. Molecular weight markers (kDa) are shown on the left. Glucose deprivation and incubation with 3-0-methylglucose resulted in a 20-30% decrease in membrane recovery. Incubation with other hexose for 12 h had no significant effect on membrane recovery protein levels and, when present with glucose, did not prevent the downregulation by glucose (Fig. 5) . Incubation of cells with 2-deoxyglucose and 3-0-metbylglucose caused a small decrease in the amount of 40 kDa transporter, but this was not sufficient to account for the extent of downregulation of 3H-2DG uptake. Glucose-6-phosphate (Fig. 5) and sucrose (not shown) had no significant effect on the amount of the 40 kDa transporter. 645 concentrations of glyceraldehyde ( > 5 mmol/1) caused loss of cell viability and a decrease in extractable intact RNA and therefore could not be tested for effects on GTmRNA.
Selective regulation of G T m R N A was indicated by the observation that beta-tubulin m R N A expression was altered in the opposite direction to GTmRNA. Glucose deprivation decreased the amount of beta-tubulin m R N A (Fig. 2) . Refeeding with glucose, mannose and glucose-6-phosphate, which downregulated G T m R N A expression, increased beta-tubulin m R N A levels (Fig.6) . Other sugars and metabolites, which did not substitute for glucose in the downregulation of G T m R N A levels, failed to increase beta-tubuIin expression. Thus, there was an inverse correlation between hexose regulation of G T m R N A and beta-tubulin m R N A levels.
Discussion
Our finding that glucose deprivation, either in the absence or presence of insulin/IGF-1, stimulates expression of the HepG2/brain-type glucose transporter at the level of m R N A in differentiated L6 myocytes confirms the report of Walker et al. [17] , although some differences are apparent; for example, we detect the induction of a 40 kDa glucose transporter protein with an anti-C-terminal antiserum whereas Walker et al. [17] detect a doublet of 43 and 46 kDa with an anti-human erythrocyte transporter antiserum. Furthermore, in our experiments a discrepancy exists in L6 cells between the effects of insulin on the levels of protein and m R N A (elevated five-to tenfold) compared to transporter activity (enhanced by only 20-30%) in glucose-deprived cells. Studies in human fibroblasts [39] and rat soleus muscle [20] have also shown G T m R N A was downregulated equally by glucose and mannose, and to a lesser extent by glucose-6-phosphate (Fig.6 ). 2-deoxyglucose and 3-O-methylglucose did not significantly alter expression of GTmRNA. Galactose and glucosamine, on the other hand, further increased G T m R N A levels by -30%, but galactose was unable to prevent the decrease caused by glucose or mannose. Mannitol and sucrose had no effect on G T m R N A levels (not shown). As 2-deoxyglucose, which is transported and phosphorylated, could not replace glucose in the downregulation of glucose transporter protein and m R N A expression, these results indicate that neither direct interaction with the transporter nor generation of hexose phosphate is sufficient to downregulate transporter m R N A and protein, suggesting that a metabolic intermediate beyond the level of glucose-6-phosphate is required. Therefore, other nutrients and metabolic substrates were tested for their ability to downregulate G T m R N A expression. The culture medium (glucosefree DME) contains pyruvate (1 mmol/1), glutamine (2 mmol/1) and other amino acids, but not alanine. Clearly, the presence of these nutrients did not prevent the induction of G T m R N A expression. Addition of excess pyruvate (10 mmol/1) and of alanine (10 mmol/1), glycerol (10 mmol/1) or glyceraldehyde (2 mmol/1) did not reverse the effect of glucose deprivation (data not shown). Higher failure of insulin to significantly stimulate glucose uptake in the glucose-deprived state. The discrepancy could be due to differential regulation by glucose deprivation and (Table 2) . Thus, 2-deoxyglucose, 3-O-methylglucose, glucosamine and mannitol downregulated 3H-2DG uptake, as described previously in fibroblasts [46, 47] and 3T3 adipocytes [25] , but these hexoses did not downregulate GTmRNA levels. On the assumption that most of the glucose transport activity in these cells is due to the HepG2/brain-type transporter, this suggests that direct interaction of hexose with the transporter is able to regulate I the intrinsic activity or membrane distribution of transporters, independent of changes in transporter transcription and translation. However, regulation of transport activity is complex because glucosamine and mannitol, which are poor competitors of glucose uptake in L6 myocytes [18, 38] , downregulated 3H-2DG uptake whereas galactose did not, consistent with previous reports [23, 25] . We are unable to directly assess the contribution of other transporter species to glucose uptake and therefore it remains possible that different glucose transporter subtypes are regulated independently by different hexoses.
The direct effect of hexose on regulation of transporter activity is also indicated by the effects of glucose-6-phosphate, which markedly increased transport activity while causing a small decrease of GTmRNA levels. Glucose-6-phosphate increases cytochalasin B binding to the glucose transporter in L6 myocytes [48] , possibly in an allosteric manner, and may therefore enhance glucose recognition and transporter activity. As glucose-6-phosphate did not compete directly for 3H-2DG uptake, we assume that it is not transported into the cell. However, a small amount of glucose-6-phosphate transported, or degraded by membrane phosphatases to glucose, may account for the small decrease in GTmRNA levels and the reciprocal increase in beta-tubulin mRNA levels. Another interpretation is that a post-translational defect develops during glucose deprivation, such that maximal stimulation of transporter protein synthesis by insulin is not realized at the level of glucose transport activity. This may be due to partial glycosylation of the glucose transporter [33, [40] [41] [42] [43] , interference with post-translation processing or insertion of transporters in the plasma membrane in the glucose-deprived state.
Independent regulation of glucose transporter activity, protein and mRNA levels by various hexoses Hexose/nutrient requirernents for downregulation of glucose transporter mRNA and protein
Reversal of the glucose deprivation effect on GTmRNA and 40 kDa transporter apparently requires both direct interaction with the transporter and metabolism beyond the level of hexose phosphate and/or maintenance of normal glycoprotein synthesis. Glucose and mannose were the only hexoses able to maximally downregulate GTmRNA and protein following glucose deprivation.
The downregulation of 3H-2DG uptake by glucose and mannose was paralleled by decreases in GTmRNA and 40 kDa transporter protein levels ( Table 2 ), implying that the decrease in transport activity is directly due to the decrease in transporter transcription or mRNA stability and translation. Previous studies have shown glucose and mannose dependent downregulation of glucose uptake [17, 25, 29, 45] and transporter protein [33] . In a study on glial ceils [16] the glucose deprivation-induced expression of glucose transporter activity and mRNA was also shown to be reversed by glucose, but the hexose specificity was not addressed. We find that hexoses other than glucose and mannose cause changes in glucose transport activity without altering glucose transporter protein and mRNA Both hexoses are equally good substrates for the transporter in L6 myocytes, are essentially interchangeable as substrates for glycolysis [49] and support normal glycoprotein synthesis. An increase in the amount of the 50 kDa transporter species after refeeding with glucose and mannose is consistent with glycosylation of some of the 40 kDa transporter species, although the total level of transporter protein remained decreased. The use of non-metabolisable glucose analogues 2-deoxyglucose and 3-0-methylglucose, which are transported by the glucose transporter but do not significantly downregulate GTmRNA or protein levels, demonstrates that neither direct interaction of hexose with the glucose transporter nor production of hexose phosphate is sufficient to reverse the glucos e deprivation effects. Therefore, it seems that metabolism of glucose beyond hexose phosphate is required to downregulate expression of the HepG2Yorain glucose transporter mRNA and protein.
Other hexose and metabolic substrates tested could not substitute for glucose and mannose in the downregulation of GTmRNA and protein. The inability of glyceraldehyde, pyruvate, glycerol and amino acids to prevent or reverse the glucose deprivation effect on GTmRNA indicates that GTmRNA expression in L6 myocytes is not regulated directly by these metabolites and is independent of general energy metabolism, consistent with the findings for the regulation of glucose transporter accumulation in 3T3-C2 cells [33] . Other potential regulators include pentose pathway intermediates, not tested in this study, which appear to be involved in the regulation of glucose transport in a mutant fibroblast cell line deficient in phosphoglucose isomerase [47] . In a detailed study of hexose regulation of glucose transporter protein accumulation in 3T3-C2 fibroblasts Haspel et al. [33] concluded that both substrate interaction with the glucose transporter and hexose phosphate metabolism or accumulation regulate the effects of glucose deprivation and refeeding. However, in this cell line no change was observed in the rate of translation or the amount of HepG2/brain glucose transporter mRNA, indicating that transporter accumulation was regulated by protein turnover. There are, therefore, cell-specific and hexose-specific pathways for regulation of the glucose transporter syste m at the levels of transcription or mRNA stability, translation, protein turnover and transporter activity.
